Royal Society of Biology
Fraser Murray is the Chief Executive Officer at Pheno Therapeutics Ltd, a company focused on discovering small molecule therapeutics for unmet medical needs. Fraser is also a Co-founder and Scientific Advisor at Pandeia Therapeutics, helping to develop treatments for Huntington's disease. Additionally, Fraser serves as an Investor Director at Tridek-One and Head of Scientific Evaluation at Advent Life Sciences. With a background in Neuroscience and Immunology, Fraser brings expertise to various ventures in the Life Sciences sector.
Royal Society of Biology
The Royal Society of Biology is a single unified voice for biology: advising Government and influencing policy; advancing education and professional development; supporting our members, and engaging and encouraging public interest in the life sciences. The Society represents a diverse membership of individuals, learned societies and other organisations. Individual members include practising scientists, students at all levels, professionals in academia, industry and education, and non-professionals with an interest in biology. Our vision is of a world that understands the true value of biology and how it can contribute to improving life for all. Our mission is to be the unifying voice for biology, to facilitate the promotion of new discoveries in biological science for national and international benefit, and to engage the wider public with our work.